Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
Clinical trial NCT05907746 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05907746
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-29
- Primary completion
- 2025-10-16
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.